Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000408963

Medchemexpress LLC Fenoldopam (mesylate) | 67227-57-0 | 99.9% | 1 ML
SDP

Catalog No. 5000408963
Encompass_Preferred

Fenoldopam mesylate is a D1 receptor agonist and a novel lysine-specific demethylase 1 (LSD1) inhibitor with an IC50 of 0.8974 μM. It exhibits anti-hypertensive effects, anti-cancer cell proliferation activity, and can induce cell apoptosis. This product is provided as a 10 mM, 1 mL solution.

  • Acts as a D1 receptor agonist
  • Novel LSD1 inhibitor with an IC50 of 0.8974 μM
  • Exhibits anti-hypertensive effects
  • Shows anti-cancer cell proliferation activity
  • Induces cell apoptosis
  • Purity of 99.94%
  • Provided as a 10 mM, 1 mL solution
  • Stable under recommended storage conditions
  • Melting/freezing point is 274°C

Catalog No. 50-004-08963 Supplier Medchemexpress LLC Supplier No. HYB0735A10MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Fenoldopam mesylate is a D1 receptor agonist and a novel lysine-specific demethylase 1 (LSD1) inhibitor with an IC50 of 0.8974 μM. It exhibits anti-hypertensive effects, anti-cancer cell proliferation activity, and can induce cell apoptosis. This product is provided as a 10 mM, 1 mL solution.

  • Acts as a D1 receptor agonist
  • Novel LSD1 inhibitor with an IC50 of 0.8974 μM
  • Exhibits anti-hypertensive effects
  • Shows anti-cancer cell proliferation activity
  • Induces cell apoptosis
  • Purity of 99.94%
  • Provided as a 10 mM, 1 mL solution
  • Stable under recommended storage conditions
  • Melting/freezing point is 274°C

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.